Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination

Parasitology Research

Volumn 113, Issue 10, 2014, Pages 3535-3546

  Abdul Ghani, Rashad ^a   Beier, John C ^b  

^a SANA A UNIVERSITY   (Yemen)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Gametocyte; Gametocytocide; Malaria transmission; Plasmodium falciparum; Sporontocide; Transmission blocking antimalarial

Indexed keywords

4 AMINOQUINOLINE; 8 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRONARIDINE; SULFADOXINE; TAFENOQUINE; 8-AMINOQUINOLINE; AMINOQUINOLINE DERIVATIVE; ARTEMISININ;

ANTIMALARIAL ACTIVITY; CHEMOTHERAPY; DISEASE ELIMINATION; DRUG MECHANISM; DRUG USE; GAMETOCYTE; HUMAN; MALARIA FALCIPARUM; META ANALYSIS (TOPIC); MOSQUITO; NONHUMAN; PARASITE TRANSMISSION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; DISEASE CARRIER; DISEASE ERADICATION; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; TRANSMISSION;

PLASMODIUM FALCIPARUM;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; ARTEMISININS; CULICIDAE; DISEASE ERADICATION; DRUG RESISTANCE; HUMANS; INSECT VECTORS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84918499383     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-014-4091-6     Document Type: Review

References (136)

1. Abay SM (2013) Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis. Parasit Vectors 6:278
2. Abdul-Ghani R, Farag H, Allam A, Azazy A (2014a) Measuring resistant-genotype transmission of malaria parasites: challenges and prospects. Parasitol Res 113:1481–1487
3. Abdul-Ghani R, Al-Maktari MT, Al-Shibani LA, Allam AF (2014b) A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs. Acta Trop 137C:44–57
4. Adjalley SH et al (2011) Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A 108:E1214–E1223
5. Adjuik M et al (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:9–17
6. Ali E, Mackinnon MJ, Abdel-Muhsin AM, Ahmed S, Walliker D, Babiker HA (2006) Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. Trans R Soc Trop Med Hyg 100:176–183
7. Aminake MN et al (2011) Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrob Agents Chemother 55:1338–1348
8. Andagalu B, Mativo J, Kamau E, Ogutu B (2014) Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission area. Malar J 13:265
9. Arango EM, Upegui YA, Carmona-Fonseca J (2012) Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia. Acta Trop 122:177–182
10. Barnes KI et al (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2:e330
11. Beavogui AH et al (2010) Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Int J Parasitol 40:1213–1220
12. Benoit-Vical F et al (2007) Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother 51:1463–1472
13. Bousema T, Drakeley C (2011) Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24:377–410
14. Bousema JT et al (2006) Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193:1151–1159
15. Bousema T et al (2010) Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J 9:136
16. Bray RS, Burgess RW, Fox RM, Miller MJ (1959) Effect of pyrimethamine upon sporogony and pre-erythrocytic schizogony of Laverania falciparum. Bull World Health Organ 21:233–238
17. Brueckner RP, Lasseter KC, Lin ET, Schuster BG (1998a) First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg 58:645–649
18. Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG (1998b) Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrob Agents Chemother 42:1293–1294
19. Buchholz K, Burke TA, Williamson KC, Wiegand RC, Wirth DF, Marti M (2011) A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis 203:1445–1453
20. Buckling AG, Taylor LH, Carlton JM, Read AF (1997) Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proc Biol Sci 264:553–559
21. Buckling A, Ranford-Cartwright LC, Miles A, Read AF (1999) Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitol 118:339–346
22. Burgess RW, Bray RS (1961) The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. Bull World Health Organ 24:451–456
23. Butcher GA (1997) Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27:975–987
24. Butterworth AS, Skinner-Adams TS, Gardiner DL, Trenholme KR (2013) Plasmodium falciparum gametocytes: with a view to a kill. Parasitology 140:1718–1734
25. Chauhan SS, Sharma M, Chauhan PM (2010) Trioxaquines: hybrid molecules for the treatment of malaria. Drug News Perspect 23:632–646
26. Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Wilairat P (2000) Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Parasitol Int 48:275–280
27. Chen PQ et al (1994) The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl) 107:709–711
28. Chiodini PL et al (1995) Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother 36:1073–1078
29. Chomcharn Y, Surathin K, Bunnag D, Sucharit S, Harinasuta T (1980) Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum. Southeast Asian J Trop Med Public Health 11:408–412
30. Chotivanich K et al (2006) Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother 50:1927–1930
31. Chutmongkonkul M, Maier WA, Seitz HM (1992) Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes. Ann Trop Med Parasitol 86:103–110
32. Coleman RE (1990) Sporontocidal activity of the antimalarial WR-238605 against Plasmodium berghei ANKA in Anopheles stephensi. Am J Trop Med Hyg 42:196–205
33. Coleman RE, Clavin AM, Milhous WK (1992) Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR mice and Anopheles stephensi mosquitoes. Am J Trop Med Hyg 46:169–182
34. Coleman RE, Nath AK, Schneider I, Song GH, Klein TA, Milhous WK (1994) Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials. Am J Trop Med Hyg 50:646–653
35. Coulibaly B et al (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS ONE 4:e5318
36. Crockett M, Kain KC (2007) Tafenoquine: a promising new antimalarial agent. Expert Opin Investig Drugs 16:705–715
37. Czesny B, Goshu S, Cook JL, Williamson KC (2009) The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrob Agents Chemother 53:4080–4085
38. Dechy-Cabaret O, Benoit-Vical F, Robert A, Meunier B (2000) Preparation and antimalarial activities of “trioxaquines”, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. Chembiochem 1:281–283
39. Dechy-Cabaret O et al (2004) Synthesis and antimalarial activity of trioxaquine derivatives. Chemistry 10:1625–1636
40. Delves MJ, Sinden RE (2010) A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malar J 9:35
41. Delves MJ et al (2012) The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med 9:e1001169
42. Drakeley CJ et al (2004) Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 9:53–61
43. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA (2006) The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol 22:424–430
44. Eastman RT, Fidock DA (2009) Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7:864–874
45. Enosse S, Butcher GA, Margos G, Mendoza J, Sinden RE, Høgh B (2000) The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine. Trans R Soc Trop Med Hyg 94:77–82
46. Giha HA (2010) Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitol Res 106:549–552
47. Giha HA, Elbashir MI, A-Elbasit IE, A-Gadir TM, ElGhazali G (2008) Bimodal transmission of cerebral malaria and severe malarial anemia and reciprocal co-existence of sexual and asexual parasitemia in an area of seasonal malaria transmission. Parasitol Res 103:81–85
48. Githeko AK, Brandling-Bennett AD, Beier M, Atieli F, Owaga M, Collins FH (1992) The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg 86:355–358
49. Gogtay NJ, Kamtekar KD, Dalvi SS, Chogle AR, Aigal U, Kshirsagar NA (2004) Preliminary report of the evaluation of the gametocytocidal action of bulaquine, in adult patients with acute, Plasmodium falciparum malaria. Ann Trop Med Parasitol 98:525–528
50. Gogtay NJ et al (2006) A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]. BMC Infect Dis 6:16
51. Govere JM, Durrheim DN, Mngomezulu NM, Barnes K, Sharp B (2003) Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg 97:707–708
52. Grande T et al (2007) A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS ONE 2:e1101
53. Graves PM, Gelband H, Garner P (2014) Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Cochrane Database Syst Rev (in press) doi: 10.1002/14651858.CD008152.pub3.
54. Hale BR et al (2003) A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis 36:541–549
55. Hallett RL et al (2004) Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother 48:3940–3943
56. Hallett RL et al (2006) Chloroquine/sulphadoxine-pyrimethamine for Gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials 1:e15
57. Handunnetti SM, Gunewardena DM, Pathirana PP, Ekanayake K, Weerasinghe S, Mendis KN (1996) Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites, and have implications for disease control. Trans R Soc Trop Med Hyg 90:563–567
58. Hawking F, Wilson ME, Gammage K (1971) Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 65:549–559
59. Hogh B et al (1998) The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg 58:176–182
60. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI (2013) G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol 81:133–201
61. Kaneko A, Kamei K, Suzuki T, Ishii A, Siagian R, Panjaitan W (1989) Gametocytocidal effect of primaquine in a chemotherapeutic malaria control trial in North Sumatra, Indonesia. Southeast Asian J Trop Med Public Health 20:351–359
62. Kiszewski AE (2011) Blocking Plasmodium falciparum malaria transmission with drugs: the gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals 4:44–68
63. Klein TA, Tada MS, Lima JBP (1991) Infection of Anopheles darlingi fed on patients with Plasmodium falciparum before and after treatment with quinine or quinine plus tetracycline. Am J Trop Med Hyg 44:604–608
64. Kone A et al (2010) Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol 40(10):1221–1228
65. Kremsner PG, Krishna S (2004) Antimalarial combinations. Lancet 364:285–294
66. Kumar N, Zheng H (1990) Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res 76:214–218
67. Lanners HN (1991) Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitol Res 77:478–481
68. Lawpoolsri S et al (2009) Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J 8:159
69. Lelièvre J, Almela MJ, Lozano S, Miguel C, Franco V, Leroy D, Herreros E (2012) Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay. PLoS ONE 7:e35019
70. Lell B et al (2000) Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 355:2041–2045
71. López-Antuñano FJ (1999) Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug? Salud Publica Mex 41:410–419
72. Mehlhorn H (ed) (2008) Encyclopedia of parasitology, 3rd edn. Heidlberg, Springer
73. Mehra N, Bhasin VK (1993) In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum. Jpn J Med Sci Biol 46:37–43
74. Méndez F et al (2002) Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 156:230–238
75. Méndez F et al (2007) Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am J Trop Med Hyg 77:438–43
76. Mens PF et al (2008) A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malar J 7:237
77. Mita T, Tanabe K, Kita K (2009) Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58:201–209
78. Mockenhaupt FP et al (2005) Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health 10:901–908
79. Müller O et al (2013) Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs. Pharmacoepidemiol Drug Saf 22:376–385
80. Murambiwa P, Masola B, Govender T, Mukaratirwa S, Musabayane CT (2011) Anti-malarial drug formulations and novel delivery systems: a review. Acta Trop 118:71–79
81. Newton PN et al (2006) Manslaughter by fake artesunate in Asia–will Africa be next? PLoS Med 3:e197
82. Nosten F, Hien TT, White NJ (1998) Use of artemisinin derivatives for the control of malaria. Med Trop (Mars) 58:45–49
83. Nosten F et al (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297–302
84. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ (2008) Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 7:125
85. Ouédraogo AL et al (2008) Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso. Acta Trop 105:28–34
86. Peatey CL et al (2010) Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob Agents Chemother 54:1334–1337
87. Peatey CL, Spicer TP, Hodder PS, Trenholme KR, Gardiner DL (2011) A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol Biochem Parasitol 180:127–131
88. Peatey CL, Leroy D, Gardiner DL, Trenholme KR (2012) Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? Malar J 11:34
89. Price RN et al (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654–1658
90. Price R et al (1999) Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60:1019–1023
91. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ (2004) Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 48:1329–1334
92. Reeve PA, Toaliu H, Kaneko A, Hall JJ, Ganczakowski M (1992) Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. J Trop Med Hyg 95:349–351
93. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD (1968) Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 38:625–632
94. Ringwald P, Meche FS, Basco LK (1999) Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. Am J Trop Med Hyg 61:446–448
95. Robert V, Molez JF, Trape JF (1996) Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in west Africa. Am J Trop Med Hyg 55:350–351
96. Robert V, Awono-Ambene HP, Le Hesran JY, Trape JF (2000) Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg 62:210–216
97. Sáenz FE, Mutka T, Udenze K, Oduola AM, Kyle DE (2012) Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Antimicrob Agents Chemother 56:4685–4692
98. Sawa P et al (2013) Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis 207:1637–1645
99. Schirmer RH et al (2003) Methylene blue as an antimalarial agent. Redox Rep 8:272–275
100. Schlitzer M (2008) Antimalarial drugs— what is in use and what is in the pipeline. Arch Pharm 341:149–163
101. Schneweis S, Maier WA, Seitz HM (1991) Haemolysis of infected erythrocytes—a trigger for formation of Plasmodium falciparum gametocytes? Parasitol Res 77:458–460
102. Shekalaghe S et al (2007) Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE 2:e1023
103. Shute PG, Maryon M (1954) The effect of pyrimethamine (daraprim) on the gametocytes and oocysts of Plasmodium falciparum and Plasmodium vivax. Trans R Soc Trop Med Hyg 48:50–63
104. Sinden RE (1982a) Gametocytogenesis of Plasmodium falciparum in vitro: an electron microscopic study. Parasitology 84:1–11
105. Sinden RE (1982b) Gametocytogenesis of Plasmodium falciparum in vitro: ultrastructural observations on the lethal action of chloroquine. Ann Trop Med Parasitol 76:15–23
106. Smalley ME (1977) Plasmodium falciparum gametocytes: the effect of chloroquine on their development. Trans R Soc Trop Med Hyg 71:526–529
107. Smalley ME, Sinden RE (1977) Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74:1–8
108. Smithuis F et al (2010) Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 10:673–681
109. Sokhna CS, Trape JF, Robert V (2001) Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite 8:243–250
110. Sowunmi A, Fateye BA (2003) Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health 8:783–792
111. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT (2008) Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine. Malar J 7:169
112. Sowunmi A et al (2009) Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children. Malar J 8:297
113. Suputtamongkol Y et al (2003) The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg 68:620–623
114. Sutanto I et al (2013) The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South Sumatra, Western Indonesia: an open-label, randomized, controlled trial. Clin Infect Dis 56:685–693
115. Sutherland CJ et al (2002) Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 67:578–585
116. Sutherland CJ et al (2005) Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2:e92
117. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V (2004) Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J 3:24
118. Tanaka TQ, Williamson KC (2011) A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol Biochem Parasitol 177:160–163
119. Tangpukdee N et al (2008) Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand. Korean J Parasitol 46:65–70
120. Targett G et al (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis 183:1254–1259
121. Taylor WR, White NJ (2004) Antimalarial drug toxicity: a review. Drug Saf 27:25–61
122. Teklehaimanot A, Nguyen-Dinh P, Collins WE, Barber AM, Campbell CC (1985) Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro. Am J Trop Med Hyg 34:429–434
123. Tjitra E, Suprianto S, Anstey NM (2002) Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. Trans R Soc Trop Med Hyg 96:434–437
124. Tripathi R, Puri SK, Dutta GP (1996) Sodium beta-artelinate—a new potential gametocytocide. Exp Parasitol 82:251–254
125. van der Kolk M, Tebo AE, Nimpaye H, Ndombol DN, Sauerwein RW, Eling WM (2003) Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent. Trans R Soc Trop Med Hyg 97:375–379
126. van Pelt-Koops JC et al (2012) The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to Anopheles mosquito vector. Antimicrob Agents Chemother 56:3544–3548
127. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G (2001a) Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65:523–527
128. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G (2001b) Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6:92–98
129. Walsh DS et al (2004) Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. J Infect Dis 190:1456–1463
130. White NJ (2008) The role of anti-malarial drugs in eliminating malaria. Malar J 7:S8
131. White NJ (2013) Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 13:175–181
132. White NJ, Olliaro PL (1996) Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today 12:399–401
133. WHO (2010) Guidelines for the treatment of malaria, 2nd edn. World Health Organization, Geneva
134. Wilairatana P, Krudsood S, Tangpukdee N (2010a) Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas. Korean J Parasitol 48:179–182
135. Wilairatana P, Tangpukdee N, Krudsood S (2010b) Long term primaquine administration to reduce Plasmodium falciparum gametocyte transmission in hypoendemic areas. Southeast Asian J Trop Med Public Health 41:1306–1311
136. Zoungrana A et al (2008) Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS ONE 3:e1630